Maison Clio Blue SA

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.3M. In comparison, MC.PA has a market cap of 230.2B. Regarding current trading prices, MLCLI.PA is priced at €1.90, while MC.PA trades at €463.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas MC.PA's P/E ratio is 21.24. In terms of profitability, MLCLI.PA's ROE is -0.77%, compared to MC.PA's ROE of +0.16%. Regarding short-term risk, MLCLI.PA is less volatile compared to MC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLCLI.PA.Check MC.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.3M. In comparison, RMS.PA has a market cap of 170B. Regarding current trading prices, MLCLI.PA is priced at €1.90, while RMS.PA trades at €1,609.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas RMS.PA's P/E ratio is 37.61. In terms of profitability, MLCLI.PA's ROE is -0.77%, compared to RMS.PA's ROE of +0.26%. Regarding short-term risk, MLCLI.PA is less volatile compared to RMS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLCLI.PA.Check RMS.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.3M. In comparison, CDI.PA has a market cap of 79.3B. Regarding current trading prices, MLCLI.PA is priced at €1.90, while CDI.PA trades at €441.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas CDI.PA's P/E ratio is 17.51. In terms of profitability, MLCLI.PA's ROE is -0.77%, compared to CDI.PA's ROE of +0.19%. Regarding short-term risk, MLCLI.PA is less volatile compared to CDI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLCLI.PA.Check CDI.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.3M. In comparison, KER.PA has a market cap of 31.4B. Regarding current trading prices, MLCLI.PA is priced at €1.90, while KER.PA trades at €256.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas KER.PA's P/E ratio is -1165.91. In terms of profitability, MLCLI.PA's ROE is -0.77%, compared to KER.PA's ROE of +0.00%. Regarding short-term risk, MLCLI.PA is less volatile compared to KER.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLCLI.PA.Check KER.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.3M. In comparison, DPT.PA has a market cap of 84.4M. Regarding current trading prices, MLCLI.PA is priced at €1.90, while DPT.PA trades at €0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas DPT.PA's P/E ratio is -8.94. In terms of profitability, MLCLI.PA's ROE is -0.77%, compared to DPT.PA's ROE of +0.03%. Regarding short-term risk, MLCLI.PA is less volatile compared to DPT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLCLI.PA.Check DPT.PA's competition here